EFFECTS OF PERINDOPRIL, TELMISARTAN, AND THEIR COMBINATIONS ON CLINICAL, FUNCTIONAL, AND OXIDATIVE STRESS PARAMETERS IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS

EFFECTS OF PERINDOPRIL, TELMISARTAN, AND THEIR COMBINATIONS ON CLINICAL, FUNCTIONAL, AND OXIDATIVE STRESS PARAMETERS IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS

.

Saved in:

Bibliographic Details
Main Authors:	Yu. N. Belenkov, E. V. Privalova, E. A. Zheleznykh, Yu. A. Danilogorskaya, I. S. Chekneva, O. A. Azizova, A. V. Aseychev, A. G. Shvachko
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2010-04-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1439
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

VASCULAR INJURY CORRECTION IN ARTERIAL HYPERTENSION: FOCUS ON PERINDOPRIL
by: Yu. N. Belenkov, et al.
Published: (2012-06-01)

INFLUENCE OF THE COMBINATION DRUG PRESTANS (PERINDOPRIL A, AMLODIPINE) ON MORPHO-FUNCTIONAL PARAMETERS OF ARTERIAL BED IN ESSENTIAL HYPERTENSION
by: Yu. A. Danilogorskaya, et al.
Published: (2017-12-01)

Nebivolol effects on myocardial remodelling, inflammation markers and endothelial dysfunction in chronic heart failure patients with or without Type 2 diabetes mellitus
by: Yu. N. Belenkov, et al.
Published: (2011-02-01)

Microcirculatory disorders in patients with coronary heart disease and type 2 diabetes
by: Yu. N. Belenkov, et al.
Published: (2014-12-01)

Neuregulin-1β, Biomarkers of Inflammation and Myocardial Fibrosis in Heart Failure Patients
by: K. A. Zhbanov, et al.
Published: (2022-11-01)

Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus
by: Yu. A. Danilogorskaya, et al.
Published: (2019-07-01)

Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches
by: A. A. Shchendrygina, et al.
Published: (2021-07-01)

Enhanced external counterpulsation in the management of patients with ischemic heart failure: long-term impact on clinical outcomes
by: A. S. Lishuta, et al.
Published: (2024-09-01)

Acute nitroglycerin test for predicting perindopril therapy effectiveness in patients with coronary heart disease and chronic heart failure
by: I. G. Fomina, et al.
Published: (2005-12-01)

Long-term effects of enhanced external counterpulsation in the management of patients with coronary artery disease complicated by heart failure: data from the EXCEL study
by: A. S. Lishuta, et al.
Published: (2024-06-01)

Long-term effects of enhanced external counterpulsation in the management of patients with ischemic chronic heart failure
by: A. S. Lishuta, et al.
Published: (2024-06-01)

Markers of Endothelial Dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, Including in Combination with Type 2 Diabetes Mellitus
by: A. V. Zhito, et al.
Published: (2020-01-01)

TELMISARTAN IN CARDIOVASCULAR RISK REDUCTION
by: О. D. Ostroumova, et al.
Published: (2018-02-01)

Comparative study of perindopril and perindopril metabolite pharmacokinetics using the HPLC/MS method
by: L. M. Krasnykh, et al.
Published: (2018-02-01)

Endothelial dysfunction and its correction with perindopril therapy in patients with coronary heart disease
by: O. A. Vartanova, et al.
Published: (2008-06-01)

Effectiveness of different treatment regimens of enhanced external counterpulsation in patients with stable coronary artery disease complicated by heart failure
by: A. S. Lishuta, et al.
Published: (2024-03-01)

Treatment of hypertension in obese patients: focus on telmisartan
by: I. E. Deneka, et al.
Published: (2018-12-01)

CENTRAL HEMODYNAMICS IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE: THE EFFECTS OF COMPLEX TREATMENT INCLUDING PERINDOPRIL/INDAPAMIDE AND LOW-INTENSITY LASER THERAPY
by: T. V. Filippova, et al.
Published: (2012-10-01)

Influence of fixed combination perindopril and indapamide on heart and vascular remodeling in hypertensive patients
by: Yu. M. Lopatin, et al.
Published: (2005-02-01)

EFFECTIVENESS OF PERINDOPRIL AND AMLODIPINE COMBINATION IN HYPERTENSIVES WITH COPD
by: O. N. Kryuchkova, et al.
Published: (2014-11-01)

LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN CORONARY HEART DISEASE: ASSESSMENT OF TELMISARTAN AND ENALAPRIL EFFECTIVENESS
by: I. P. Tatarchenko, et al.
Published: (2010-02-01)

Perindopril effects on circadian heart rate variability in patients with coronary heart disease and stable angina
by: N. A. Shardanov, et al.
Published: (2007-08-01)

COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY
by: I. V. Zhirov, et al.
Published: (2015-09-01)

About the classification of heart failure
by: A. S. Galyavich, et al.
Published: (2023-09-01)

Pharmacokinetic and Bioequivalence Study of Telzap AM<sup>®</sup> (Telmisartan/amlodipine Fixed-dose Combination) and Coadministered Mikardis<sup>®</sup> (Telmisartan) and Norvask<sup>®</sup> (Amlodipine) in Healthy Subjects
by: V. Kubesh, et al.
Published: (2020-11-01)

TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY
by: V. I. Podzolkov, et al.
Published: (2015-12-01)

The Effect of Enhanced External Counterpulsation on the Vascular State, Indicators of Glycemic Control and Quality of Life in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus
by: O. A. Slepova, et al.
Published: (2022-07-01)

THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL
by: A. I. Malyhina, et al.
Published: (2015-09-01)

Telmisartan in the hypertension treatment: from pharmacological characteristics to clinical benefits
by: E. V. Sayutina, et al.
Published: (2020-03-01)

Hypertrophic Cardiomyopathy and Connective Tissue Dysplasia Syndrome: Comorbidity Variants
by: Yu. N. Belenkov, et al.
Published: (2016-11-01)

ACHIEVEMENT OF ARTERIAL HYPERTENSION CONTROL VIA APPLICATION OF PERINDOPRIL ARGININE AND AMLODIPINE COMBINATION
by: O. N. Kryuchkova, et al.
Published: (2015-12-01)

Modern views on β-adrenoblocker therapy in elderly patients with chronic heart failure
by: E. V. Privalova
Published: (2007-06-01)

COMPARATIVE EFFECTIVENESS OF PERINDOPRIL AND LOSARTAN IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY
by: S. V. Nedogoda, et al.
Published: (2012-02-01)

Comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesity
by: S. V. Nedogoda, et al.
Published: (1970-01-01)

Planning and Evaluation of Bioequivalence Studies of Telmisartan Generic Drug Products
by: A. L. Khokhlov, et al.
Published: (2019-09-01)

Ischemic heart disease and reflux-esophagitis: complexities of the differential diagnosis and treatment.
by: Yu. N. Belenkov, et al.
Published: (2011-05-01)

THE INFLUENCE OF LONG-TERM THERAPY WITH PERINDOPRIL ON THE HEART INOTROPIC FUNCTION IN PATIENTS WITH CHRONIC POSTINFARCTION ANEURISM
by: I. G. Fomina, et al.
Published: (2016-01-01)

COMPARISON OF ENALAPRIL AND PERINDOPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND LEFT VENTRICLE SYSTOLIC DYSFUNCTION
by: Yu. I. Grinshtein, et al.
Published: (2016-01-01)

The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA
by: O. D. Ostroumova, et al.
Published: (2020-05-01)

Plasma Level’s of Neuregulin-1 in Healthy People
by: K. A. Zhbanov, et al.
Published: (2022-01-01)